# Evaluation of Clinical Outcomes According to HER2 Detection by Fluorescence In Situ Hybridization in Women with Metastatic Breast Cancer Treated with Trastuzumab

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/evaluation-of-clinical-outcomes-according-to-her2-detection-by-fluorescence-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | R. Mass,Michael F. Press,Steven M. Anderson,Melody Cobleigh,Charles L. Vogel,Noël Dybdal,Grazyna Leiberman,Dennis J. Slamon |
| Citations | 364 |
| DOI | 10.3816/cbc.2005.n.026 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2112621891 |
| PMID | 16137435 |
| Type | article |
| Year | 2005 |

## Paper authors

- [Steven M. Anderson](https://scholariq.org/researchers/steven-m-anderson/)

## Paper journal

- [Clinical Breast Cancer](https://scholariq.org/journals/clinical-breast-cancer/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.